EICHORCondition: Lupus Erythematosus · Lupus Nephritis · Sponsor: Biocon Limited
This is a multi-center study to evaluate the safety, tolerability, PK, PD, and clinical activity of itolizumab (EQ001) in subjects with Systemic Lupus Erythematosus with or without Active Proliferative Lupus Nephritis
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| AKDHC Medical Research Services, LLC | Sun City, Arizona, United States | — |
| California Institute of Renal Research | Chula Vista, California, United States | — |
| University of California San Diego Perlman Ambulatory Clinic | La Jolla, California, United States | — |
| Clinical Research of West Florida - Clearwater | Clearwater, Florida, United States | — |
| Centre for Rheumatology, Immunology and Arthritis | Fort Lauderdale, Florida, United States | — |
| University of Florida, Division of Rheumatology | Gainesville, Florida, United States | — |
| Clinical Site Partners Leesburg, LLC | Leesburg, Florida, United States | — |
| SouthCoast Research Center Inc | Miami, Florida, United States | — |
| Hope Clinical Trials | Miami, Florida, United States | — |
| Omega Research Maitland, LLC | Orlando, Florida, United States | — |
| Clinical Research of West Florida - Tampa | Tampa, Florida, United States | — |
| University of South Florida | Tampa, Florida, United States | — |
+ 13 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04128579